Objective:

To reflect on the regulatory evolution of contact lenses over the past 40 years.

Approach:

Key Findings:

• The FDA initiated regulation of soft contact lenses in the late 1960s.
• The current regulatory landscape involves a dual-agency system with the FDA and FTC.

Interpretation:

The evolution of contact lens regulation reflects ongoing changes in policy and its impact on patient care.

Conclusion:

The regulatory journey of contact lenses illustrates the complex relationship between policy development and patient care in the optical industry.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.